接受体外膜氧合成人患者的CNS并发症
该研究为澳大利亚一家体外膜氧合转诊中心的单中心回顾性队列,纳入2009至2017年连续412例接受体外膜氧合的成人患者。55例(13.3%)经CT或MRI证实存在CNS并发症,包括缺血性卒中(7.0%)、脑出血(3.4%)、缺氧缺血性脑病(3.6%)和脊髓损伤(1.2%)。静脉-动脉、静脉-静脉和静脉-肺动脉体外膜氧合亚组的CNS并发症发生率分别为18.0%、4.6%和13.6%。神经系统并发症与使用静脉-动脉体外膜氧合(p=0.002)和肾脏替代治疗(p=0.04)独立相关。有神经系统并发症的患者住院死亡率为65%,无此并发症者为32%(p<0.001)。
要点
- 412例成人体外膜氧合患者中55例(13.3%)经CT或MRI证实CNS并发症,包括缺血性卒中7.0%、脑出血3.4%、缺氧缺血性脑病3.6%、脊髓损伤1.2%。
- 静脉-动脉、静脉-静脉和静脉-肺动脉体外膜氧合亚组的CNS并发症发生率分别为18.0%、4.6%和13.6%。
- 神经系统并发症与使用静脉-动脉体外膜氧合(p=0.002)和肾脏替代治疗(p=0.04)独立相关。
- 有神经系统并发症者住院死亡率为65%,无此并发症者为32%(p<0.001)。
- 静脉-动脉体外膜氧合、肾脏替代治疗和体外膜氧合支持天数与医院死亡相关,多变量回归调整后仍相关(p=0.01、p<0.001、p=0.003)。
适用人群与场景
- 2009至2017年澳大利亚一家体外膜氧合转诊中心连续纳入的412例接受体外膜氧合的成人患者。
研究设计与关键结果
- 研究类型为单中心回顾性队列,纳入412例连续成人体外膜氧合患者,CNS并发症经CT或MRI证实。
- 55例(13.3%)发生CNS并发症:缺血性卒中7.0%、脑出血3.4%、缺氧缺血性脑病3.6%、脊髓损伤1.2%。
- 静脉-动脉、静脉-静脉和静脉-肺动脉体外膜氧合亚组的CNS并发症发生率分别为18.0%、4.6%和13.6%。
- 神经系统并发症与使用静脉-动脉体外膜氧合(p=0.002)和肾脏替代治疗(p=0.04)独立相关。
- 有神经系统并发症者住院死亡率为65%,无此并发症者为32%(p<0.001)。
- 静脉-动脉体外膜氧合、肾脏替代治疗和体外膜氧合支持天数与医院死亡相关,多变量回归调整后仍相关(p=0.01、p<0.001、p=0.003)。
证据类型、等级与局限
- 证据类型:单中心回顾性队列研究。
- 局限:原文未报告局限性。
对床旁实践的改变
- 作者认为,CNS并发症似乎更多见于需要循环支持而非呼吸支持的体外膜氧合患者,并与死亡率独立相关。
- 作者指出,尚不清楚这些并发症是导致不良结局的原因还是基础疾病严重程度的标志。
- 作者认为,需要进一步研究通过更好的患者选择和改变 ongoing care 来阐明可修改或可预防的方面。
提炼说明
- 本条依据论文摘要整理;摘要未涉及「诊断标准与关键阈值」「处置流程与药物剂量」「红旗征与不能漏的情况」「指南或共识出处」,故未列出这些栏目;全文请点「阅读原文」。
英文原文(摘要)· 点击展开
OBJECTIVES: To describe the incidence and outcomes of radiologically confirmed acute CNS complications in extracorporeal membrane oxygenation patients at an Australian extracorporeal membrane oxygenation referral center and identify associated patient characteristics.
DESIGN: Retrospective cohort study.
SETTING: Single-center tertiary institution.
PATIENTS: Four-hundred twelve consecutive adult patients supported with extracorporeal membrane oxygenation from 2009 to 2017.
RESULTS: Fifty-five patients (13.3%) had a CNS complication confirmed by CT or MRI, including ischemic stroke (7.0%), intracerebral hemorrhage (3.4%), hypoxic ischemic encephalopathy (3.6%), and spinal cord injury (1.2%). CNS complication rates in the venoarterial, venovenous, and veno-pulmonary artery extracorporeal membrane oxygenation subgroups were 18.0%, 4.6%, and 13.6%, respectively. Neurologic complications were independently associated with the use of venoarterial extracorporeal membrane oxygenation (p = 0.002) and renal replacement therapy (p = 0.04). Sixty-five percent of patients with a neurologic complication died during their hospital admission compared with 32% of patients without this complication (p < 0.001). Venoarterial extracorporeal membrane oxygenation, renal replacement therapy, and days of extracorporeal membrane oxygenation support were also associated with hospital mortality and remained so after adjustment in a multivariable regression model (p = 0.01, p < 0.001, and p = 0.003, respectively).
CONCLUSIONS: CNS complications appear to occur more frequently in patients requiring circulatory as opposed to respiratory support on extracorporeal membrane oxygenation and are independently associated with mortality. It remains unclear if these complications are causative of a poor outcome or a marker of severity of the underlying condition. Further research is required to better elucidate modifiable or preventable aspects through better patient selection and change in ongoing care.
参考来源
- Chapman JT, Breeding J, Kerr SJ, et al. CNS Complications in Adult Patients Treated With Extracorporeal Membrane Oxygenation. Crit Care Med. 2021. PMID: 33332815. doi:10.1097/CCM.0000000000004789
供执业医师抢救与诊疗参考,不替代临床判断;剂量请结合体重、肝肾功能和本院药品规格复核,以指南原文为准。